Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2026-01-05 @ 5:14 PM
Study NCT ID:
NCT01969266
Status:
COMPLETED
Last Update Posted:
2014-02-13
First Post:
2013-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pharmacokinetic Study in Healthy Participants to Assess the Pharmacokinetics and Safety of a Supratherapeutic Dose of PCI-32765 (Ibrutinib) Capsule and Solution Formulations Administered With Food
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10
Start Date Type:
None
Primary Completion Date:
2013-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-19
First Submit QC Date:
None
Study First Post Date:
2013-10-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-12
Last Update Post Date:
2014-02-13
Last Update Post Date Type:
ESTIMATED